Skip to main navigation Skip to search Skip to main content

Global mortality from conditions with skin manifestations

  • Lindsay N. Boyers
  • , Chante Karimkhani
  • , Mohsen Naghavi
  • , David Sherwood
  • , David J. Margolis
  • , Roderick J. Hay
  • , Hywel C. Williams
  • , Luigi Naldi
  • , Luc E. Coffeng
  • , Martin A. Weinstock
  • , Cory A. Dunnick
  • , Hannah Pederson
  • , Theo Vos
  • , Robert P. Dellavalle*
  • *Corresponding author for this work
  • Georgetown University School of Medicine
  • Columbia University
  • Institute for Health Metrics and Evaluation
  • University of Colorado Boulder
  • UPenn School of Medicine
  • King’s College Hospital
  • University of Nottingham
  • Azienda Ospedaliera Papa Giovanni XXIII
  • Brown University
  • Rhode Island Hospital
  • University of Colorado Anschutz Medical Campus
  • Department of Veterans Affairs
  • University of Colorado School of Medicine
  • University of Washington

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)

Abstract

Background:

 Global Burden of Disease Study is a research database containing systematically compiled information from vital statistics and epidemiologic literature to inform research, public policy, and resource allocation. 

Objective:

 We sought to compare mortality among conditions with skin manifestations in 50 developed and 137 developing countries from 1990 to 2010. 

Methods:

 This was a cross-sectional study to calculate mean age-standardized mortality (per 100,000 persons) across countries for 10 disease categories with skin manifestations. We compared differences in mortality from these disorders by time period (year 1990 vs year 2010) and by developing versus developed country status. 

Results:

 Melanoma death rates were 5.6 and 4.7 times greater in developed compared with developing countries in 1990 and 2010, respectively. Measles death rates in 1990 and 2010 were 345 and 197 times greater in developing countries, and corresponding syphilis death rates were 33 and 45 times greater. 

Limitations:

 Inability to adjust for patient-, provider-, and geographic-level confounders may limit the accuracy and generalizability of these results. 

Conclusion:

 The mortality burden from skin-related conditions differs between developing and developed countries, with the greatest differences observed for melanoma, measles, and syphilis. These results may help prioritize and optimize efforts to prevent and treat these disorders.

Original languageEnglish
Pages (from-to)1137-1143.e17
JournalJournal of the American Academy of Dermatology
Volume71
Issue number6
DOIs
Publication statusPublished - 1 Dec 2014
Externally publishedYes

Bibliographical note

Funding Information:
The Global Burden of Disease Study 2010 was supported in part by the Bill and Melinda Gates Foundation (grant number: OPP43650_01 ).

Publisher Copyright:
© 2014 American Academy of Dermatology, Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Global mortality from conditions with skin manifestations'. Together they form a unique fingerprint.

Cite this